サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1765149

灌流システムの世界市場

Perfusion Systems

出版日
ページ情報
英文 193 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=148.47円
灌流システムの世界市場
出版日: 2025年07月09日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 193 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

灌流システムの世界市場は2030年までに16億米ドルに達する

2024年に12億米ドルと推定される灌流システムの世界市場は、2030年には16億米ドルに達し、分析期間2024-2030年のCAGRは4.4％で成長すると予測されます。本レポートで分析したセグメントの1つである心肺灌流システムは、CAGR 3.4％を記録し、分析期間終了時には6億7,100万米ドルに達すると予測されています。Cell灌流システム分野の成長率は、分析期間中CAGR 4.1%と推定されます。

米国市場は3億3,600万米ドルと推定、中国はCAGR 4.1％で成長予測

米国の灌流システム市場は、2024年に3億3,600万米ドルと推定されます。世界第2位の経済大国である中国は、分析期間2024-2030年のCAGRを4.1%として、2030年までに2億5,490万米ドルの市場規模に達すると予測されています。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ4.0％と3.6％と予測されています。欧州では、ドイツがCAGR 4.5%で成長すると予測されています。

世界の灌流システム市場- 主要動向と促進要因のまとめ

灌流システムは医療手順にどのような革命をもたらすか？

灌流システムは、手術やその他の重要な医療介入において、組織や臓器に酸素や必須栄養素を効果的に供給することで、現代の医療手順において重要な役割を果たしています。これらのシステムは、心肺バイパス手術、臓器移植、さまざまな形態の集中治療において不可欠です。例えば開心術では、灌流システムが一時的に心臓と肺の機能を代行し、血液循環と酸素供給を維持します。この機能は、複雑な外科手術の成功に不可欠であり、患者の予後を大幅に改善しました。さらに、臓器移植においては、灌流システムは臓器を体外に保存するために使用され、移植可能な時間を延長し、ドナー臓器の生存率を向上させます。灌流システムの精度と信頼性は、外科手術とクリティカルケアの分野に革命をもたらし、より複雑で救命処置が安全に行えるようになりました。

どのような技術革新が灌流システムを形成しているのでしょうか？

技術革新は灌流システムの進歩の最前線にあり、効率性、安全性、機能性を向上させています。注目すべき開発の一つは、高度なモニタリングと制御技術の統合であり、これによって灌流パラメーターのリアルタイム評価と調整が可能になりました。これにより、最適な灌流条件が確保され、合併症のリスクが軽減されます。もう一つの重要な技術革新は、灌流装置の構造に生体適合性のある材料やコーティングを使用することで、副作用のリスクを最小限に抑え、患者の安全性を高めています。さらに、ポータブルで低侵襲な灌流システムの出現により、その用途は手術室だけでなく、野戦病院や救急現場にも広がっています。また、ソフトウェアとデータ解析の進歩により、より正確な制御とモニタリングが可能になり、外科手術と非外科手術の両方で治療成績が向上しています。このような技術の進歩により、灌流システムはより多用途で効果的なものとなり、医療従事者の進化するニーズに応えています。

灌流システムは様々な医療分野でどのように使用されていますか？

灌流システムは、幅広い医療分野で活用されており、それぞれの機能を活かして患者さんのケアを向上させています。循環器領域では、冠動脈バイパス術や弁置換術に不可欠なシステムです。移植医療では、灌流システムは腎臓、肝臓、心臓などの臓器の生存能力を維持・向上させ、移植を成功させ、待ち時間を短縮します。腫瘍学では、灌流システムは、高用量の化学療法を特定の部位に投与し、全身的な副作用を最小限に抑えるための、四肢隔離灌流技術に使用されています。さらに、クリティカルケアでは、体外膜酸素療法（ECMO）が灌流技術の救命的応用であり、重篤な心臓や肺の状態の患者に長時間の心臓や呼吸のサポートを提供しています。灌流システムの多用途性と有効性は、このような様々な用途において、治療と患者の転帰を向上させる上で極めて重要な役割を担っています。

灌流システム市場の成長を促進する要因は？

灌流システム市場の成長は、いくつかの要因によって牽引されています。主な促進要因の1つは、心血管疾患の有病率の増加と心臓手術および介入に対する需要の高まりです。高齢者は灌流システムに依存する手術を必要とする可能性が高いため、世界人口の高齢化も市場拡大に寄与しています。より洗練されたポータブル灌流装置の開発などの技術的進歩は、応用範囲の拡大や患者の転帰の改善によって市場成長をさらに後押ししています。さらに、臓器移植が重視されるようになり、臓器保存技術の継続的な向上が灌流システムの需要を押し上げています。腫瘍学や再生医療などの新興分野で灌流システムの使用が拡大していることも、大きな成長促進要因となっています。ヘルスケアプロバイダーが治療効果や患者ケアの向上を目指す中、先進的な灌流システムの需要は増加し、今後数年間は堅調な市場成長が見込まれます。

セグメント

アプリケーション（心肺灌流システム、細胞灌流システム、生体外臓器灌流システム）

調査対象企業の例

  • ALA Scientific Instruments, Inc.
  • Getinge AB
  • Harvard Bioscience, Inc.
  • Lifeline Scientific, Inc.
  • LivaNova PLC
  • Medtronic PLC
  • Merck KgaA
  • Nipro Corporation
  • Repligen Corporation
  • Spectrum Laboratories, Inc.
  • Terumo Corporation
  • Xenios AG
  • XVIVO Perfusion AB

AIインテグレーション

Global Industry Analystsは、有効な専門家コンテンツとAIツールにより、市場情報と競合情報を変革します。

Global Industry Analystsは、一般的なLLMや業界別SLMのクエリに従う代わりに、ビデオ記録、ブログ、検索エンジン調査、大量の企業、製品/サービス、市場データなど、世界中の専門家から収集したコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • その他欧州
  • アジア太平洋
  • その他の地域

第4章 競合

目次
Product Code: MCP13918

Global Perfusion Systems Market to Reach US$1.6 Billion by 2030

The global market for Perfusion Systems estimated at US$1.2 Billion in the year 2024, is expected to reach US$1.6 Billion by 2030, growing at a CAGR of 4.4% over the analysis period 2024-2030. Cardiopulmonary Perfusion Systems, one of the segments analyzed in the report, is expected to record a 3.4% CAGR and reach US$671.0 Million by the end of the analysis period. Growth in the Cell Perfusion Systems segment is estimated at 4.1% CAGR over the analysis period.

The U.S. Market is Estimated at US$336.0 Million While China is Forecast to Grow at 4.1% CAGR

The Perfusion Systems market in the U.S. is estimated at US$336.0 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$254.9 Million by the year 2030 trailing a CAGR of 4.1% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 4.0% and 3.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.5% CAGR.

Global Perfusion Systems Market - Key Trends and Drivers Summarized

How Do Perfusion Systems Revolutionize Medical Procedures?

Perfusion systems play a crucial role in modern medical procedures by ensuring the effective delivery of oxygen and essential nutrients to tissues and organs during surgeries and other critical medical interventions. These systems are indispensable in cardiopulmonary bypass surgeries, organ transplantation, and various forms of intensive care. During open-heart surgery, for example, perfusion systems temporarily take over the function of the heart and lungs, maintaining blood circulation and oxygenation. This capability is vital for the success of complex surgical procedures and has significantly improved patient outcomes. Moreover, in organ transplantation, perfusion systems are used to preserve organs outside the body, extending the time available for transplantation and improving the viability of donor organs. The precision and reliability of perfusion systems have revolutionized the field of surgery and critical care, enabling more complex and life-saving procedures to be performed safely.

What Technological Innovations Are Shaping Perfusion Systems?

Technological innovations are at the forefront of advancements in perfusion systems, enhancing their efficiency, safety, and functionality. One notable development is the integration of advanced monitoring and control technologies, which allow for real-time assessment and adjustment of perfusion parameters. This ensures optimal perfusion conditions and reduces the risk of complications. Another significant innovation is the use of biocompatible materials and coatings in the construction of perfusion devices, which minimizes the risk of adverse reactions and enhances patient safety. Additionally, the advent of portable and minimally invasive perfusion systems has expanded their use beyond the operating room to include field hospitals and emergency settings. Advances in software and data analytics also enable more precise control and monitoring, improving outcomes in both surgical and non-surgical applications. These technological strides are making perfusion systems more versatile and effective, meeting the evolving needs of healthcare providers.

How Are Perfusion Systems Applied in Various Medical Fields?

Perfusion systems are applied across a broad spectrum of medical fields, each leveraging their capabilities to enhance patient care. In cardiovascular medicine, these systems are essential for procedures like coronary artery bypass grafting and valve replacement surgeries. In transplantation medicine, perfusion systems preserve and enhance the viability of organs such as kidneys, livers, and hearts, facilitating successful transplants and reducing waiting times. In oncology, perfusion systems are used in isolated limb perfusion techniques to deliver high doses of chemotherapy to specific areas, minimizing systemic side effects. Additionally, in critical care, extracorporeal membrane oxygenation (ECMO) is a life-saving application of perfusion technology, providing prolonged cardiac and respiratory support to patients with severe heart and lung conditions. The versatility and effectiveness of perfusion systems in these varied applications underscore their vital role in advancing medical treatment and patient outcomes.

What Factors Are Driving the Growth in the Perfusion Systems Market?

The growth in the perfusion systems market is driven by several factors. One of the primary drivers is the increasing prevalence of cardiovascular diseases and the rising demand for cardiac surgeries and interventions. The aging global population is also contributing to the market expansion, as older individuals are more likely to require surgeries that depend on perfusion systems. Technological advancements, such as the development of more sophisticated and portable perfusion devices, are further propelling market growth by expanding the range of applications and improving patient outcomes. Additionally, the growing emphasis on organ transplantation and the continuous improvement in organ preservation techniques are boosting the demand for perfusion systems. The expanding use of perfusion systems in emerging fields such as oncology and regenerative medicine is also a significant growth driver. As healthcare providers seek to enhance treatment efficacy and patient care, the demand for advanced perfusion systems is set to increase, ensuring robust market growth in the coming years.

SCOPE OF STUDY:

The report analyzes the Perfusion Systems market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Application (Cardiopulmonary Perfusion Systems, Cell Perfusion Systems, EX Vivo Organ Perfusion System)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 44 Featured) -

  • ALA Scientific Instruments, Inc.
  • Getinge AB
  • Harvard Bioscience, Inc.
  • Lifeline Scientific, Inc.
  • LivaNova PLC
  • Medtronic PLC
  • Merck KgaA
  • Nipro Corporation
  • Repligen Corporation
  • Spectrum Laboratories, Inc.
  • Terumo Corporation
  • Xenios AG
  • XVIVO Perfusion AB

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Global Economic Update
    • Perfusion Systems - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Advances in Organ Preservation Technologies Propel Growth in Perfusion Systems Market
    • Increasing Demand for Minimally Invasive Surgical Procedures Strengthens Business Case for Perfusion Systems
    • Technological Innovations in Perfusion Pumps Accelerate Market Adoption
    • Rising Prevalence of Cardiovascular Diseases Spurs Demand for Perfusion Systems
    • Expansion of Organ Transplantation Procedures Generates Market Opportunities
    • Growing Investments in Healthcare Infrastructure Sustain Market Growth
    • Adoption of Portable and Compact Perfusion Systems Expands Addressable Market
    • Increasing Focus on Patient Safety and Outcome Improves Demand for Advanced Perfusion Systems
    • Regulatory Approvals and Compliance Requirements Propel Market Growth
    • Development of Smart Perfusion Systems with Real-Time Monitoring Throws Spotlight on Technological Advancements
    • Rising Geriatric Population Drives Demand for Cardiac Perfusion Systems
    • Increasing Number of Critical Care Units Drives Adoption of Perfusion Systems
    • Strategic Collaborations and Partnerships in Healthcare Sector Strengthen Market Growth
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Perfusion Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Perfusion Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 3: World 15-Year Perspective for Perfusion Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2015, 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Cardiopulmonary Perfusion Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Cardiopulmonary Perfusion Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 6: World 15-Year Perspective for Cardiopulmonary Perfusion Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Cell Perfusion Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Cell Perfusion Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 9: World 15-Year Perspective for Cell Perfusion Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 10: World Perfusion Systems Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for EX Vivo Organ Perfusion System by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for EX Vivo Organ Perfusion System by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for EX Vivo Organ Perfusion System by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Perfusion Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 14: USA Recent Past, Current & Future Analysis for Perfusion Systems by Application - Cardiopulmonary Perfusion Systems, Cell Perfusion Systems and EX Vivo Organ Perfusion System - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 15: USA Historic Review for Perfusion Systems by Application - Cardiopulmonary Perfusion Systems, Cell Perfusion Systems and EX Vivo Organ Perfusion System Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 16: USA 15-Year Perspective for Perfusion Systems by Application - Percentage Breakdown of Value Sales for Cardiopulmonary Perfusion Systems, Cell Perfusion Systems and EX Vivo Organ Perfusion System for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 17: Canada Recent Past, Current & Future Analysis for Perfusion Systems by Application - Cardiopulmonary Perfusion Systems, Cell Perfusion Systems and EX Vivo Organ Perfusion System - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 18: Canada Historic Review for Perfusion Systems by Application - Cardiopulmonary Perfusion Systems, Cell Perfusion Systems and EX Vivo Organ Perfusion System Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 19: Canada 15-Year Perspective for Perfusion Systems by Application - Percentage Breakdown of Value Sales for Cardiopulmonary Perfusion Systems, Cell Perfusion Systems and EX Vivo Organ Perfusion System for the Years 2015, 2025 & 2030
  • JAPAN
    • Perfusion Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 20: Japan Recent Past, Current & Future Analysis for Perfusion Systems by Application - Cardiopulmonary Perfusion Systems, Cell Perfusion Systems and EX Vivo Organ Perfusion System - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 21: Japan Historic Review for Perfusion Systems by Application - Cardiopulmonary Perfusion Systems, Cell Perfusion Systems and EX Vivo Organ Perfusion System Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 22: Japan 15-Year Perspective for Perfusion Systems by Application - Percentage Breakdown of Value Sales for Cardiopulmonary Perfusion Systems, Cell Perfusion Systems and EX Vivo Organ Perfusion System for the Years 2015, 2025 & 2030
  • CHINA
    • Perfusion Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 23: China Recent Past, Current & Future Analysis for Perfusion Systems by Application - Cardiopulmonary Perfusion Systems, Cell Perfusion Systems and EX Vivo Organ Perfusion System - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 24: China Historic Review for Perfusion Systems by Application - Cardiopulmonary Perfusion Systems, Cell Perfusion Systems and EX Vivo Organ Perfusion System Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 25: China 15-Year Perspective for Perfusion Systems by Application - Percentage Breakdown of Value Sales for Cardiopulmonary Perfusion Systems, Cell Perfusion Systems and EX Vivo Organ Perfusion System for the Years 2015, 2025 & 2030
  • EUROPE
    • Perfusion Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 26: Europe Recent Past, Current & Future Analysis for Perfusion Systems by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 27: Europe Historic Review for Perfusion Systems by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 28: Europe 15-Year Perspective for Perfusion Systems by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 29: Europe Recent Past, Current & Future Analysis for Perfusion Systems by Application - Cardiopulmonary Perfusion Systems, Cell Perfusion Systems and EX Vivo Organ Perfusion System - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 30: Europe Historic Review for Perfusion Systems by Application - Cardiopulmonary Perfusion Systems, Cell Perfusion Systems and EX Vivo Organ Perfusion System Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 31: Europe 15-Year Perspective for Perfusion Systems by Application - Percentage Breakdown of Value Sales for Cardiopulmonary Perfusion Systems, Cell Perfusion Systems and EX Vivo Organ Perfusion System for the Years 2015, 2025 & 2030
  • FRANCE
    • Perfusion Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 32: France Recent Past, Current & Future Analysis for Perfusion Systems by Application - Cardiopulmonary Perfusion Systems, Cell Perfusion Systems and EX Vivo Organ Perfusion System - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: France Historic Review for Perfusion Systems by Application - Cardiopulmonary Perfusion Systems, Cell Perfusion Systems and EX Vivo Organ Perfusion System Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 34: France 15-Year Perspective for Perfusion Systems by Application - Percentage Breakdown of Value Sales for Cardiopulmonary Perfusion Systems, Cell Perfusion Systems and EX Vivo Organ Perfusion System for the Years 2015, 2025 & 2030
  • GERMANY
    • Perfusion Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 35: Germany Recent Past, Current & Future Analysis for Perfusion Systems by Application - Cardiopulmonary Perfusion Systems, Cell Perfusion Systems and EX Vivo Organ Perfusion System - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Germany Historic Review for Perfusion Systems by Application - Cardiopulmonary Perfusion Systems, Cell Perfusion Systems and EX Vivo Organ Perfusion System Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 37: Germany 15-Year Perspective for Perfusion Systems by Application - Percentage Breakdown of Value Sales for Cardiopulmonary Perfusion Systems, Cell Perfusion Systems and EX Vivo Organ Perfusion System for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 38: Italy Recent Past, Current & Future Analysis for Perfusion Systems by Application - Cardiopulmonary Perfusion Systems, Cell Perfusion Systems and EX Vivo Organ Perfusion System - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Italy Historic Review for Perfusion Systems by Application - Cardiopulmonary Perfusion Systems, Cell Perfusion Systems and EX Vivo Organ Perfusion System Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 40: Italy 15-Year Perspective for Perfusion Systems by Application - Percentage Breakdown of Value Sales for Cardiopulmonary Perfusion Systems, Cell Perfusion Systems and EX Vivo Organ Perfusion System for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Perfusion Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 41: UK Recent Past, Current & Future Analysis for Perfusion Systems by Application - Cardiopulmonary Perfusion Systems, Cell Perfusion Systems and EX Vivo Organ Perfusion System - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 42: UK Historic Review for Perfusion Systems by Application - Cardiopulmonary Perfusion Systems, Cell Perfusion Systems and EX Vivo Organ Perfusion System Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 43: UK 15-Year Perspective for Perfusion Systems by Application - Percentage Breakdown of Value Sales for Cardiopulmonary Perfusion Systems, Cell Perfusion Systems and EX Vivo Organ Perfusion System for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 44: Rest of Europe Recent Past, Current & Future Analysis for Perfusion Systems by Application - Cardiopulmonary Perfusion Systems, Cell Perfusion Systems and EX Vivo Organ Perfusion System - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Rest of Europe Historic Review for Perfusion Systems by Application - Cardiopulmonary Perfusion Systems, Cell Perfusion Systems and EX Vivo Organ Perfusion System Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 46: Rest of Europe 15-Year Perspective for Perfusion Systems by Application - Percentage Breakdown of Value Sales for Cardiopulmonary Perfusion Systems, Cell Perfusion Systems and EX Vivo Organ Perfusion System for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Perfusion Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 47: Asia-Pacific Recent Past, Current & Future Analysis for Perfusion Systems by Application - Cardiopulmonary Perfusion Systems, Cell Perfusion Systems and EX Vivo Organ Perfusion System - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Asia-Pacific Historic Review for Perfusion Systems by Application - Cardiopulmonary Perfusion Systems, Cell Perfusion Systems and EX Vivo Organ Perfusion System Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 49: Asia-Pacific 15-Year Perspective for Perfusion Systems by Application - Percentage Breakdown of Value Sales for Cardiopulmonary Perfusion Systems, Cell Perfusion Systems and EX Vivo Organ Perfusion System for the Years 2015, 2025 & 2030
  • REST OF WORLD
    • TABLE 50: Rest of World Recent Past, Current & Future Analysis for Perfusion Systems by Application - Cardiopulmonary Perfusion Systems, Cell Perfusion Systems and EX Vivo Organ Perfusion System - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Rest of World Historic Review for Perfusion Systems by Application - Cardiopulmonary Perfusion Systems, Cell Perfusion Systems and EX Vivo Organ Perfusion System Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 52: Rest of World 15-Year Perspective for Perfusion Systems by Application - Percentage Breakdown of Value Sales for Cardiopulmonary Perfusion Systems, Cell Perfusion Systems and EX Vivo Organ Perfusion System for the Years 2015, 2025 & 2030

IV. COMPETITION